|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005940,
umls-concept:C0008976,
umls-concept:C0036525,
umls-concept:C0043603,
umls-concept:C0205474,
umls-concept:C0231220,
umls-concept:C0439849,
umls-concept:C0871261,
umls-concept:C1522484,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1998-3-18
|
|
pubmed:abstractText |
The aim of this study was to evaluate pamidronate for bone pain in a randomised double-blind trial and to evaluate the contribution of new markers of bone resorption in patients with bone metastases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1243-50
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9496390-Adult,
pubmed-meshheading:9496390-Aged,
pubmed-meshheading:9496390-Bone Neoplasms,
pubmed-meshheading:9496390-Bone Resorption,
pubmed-meshheading:9496390-Diphosphonates,
pubmed-meshheading:9496390-Double-Blind Method,
pubmed-meshheading:9496390-Female,
pubmed-meshheading:9496390-Humans,
pubmed-meshheading:9496390-Male,
pubmed-meshheading:9496390-Middle Aged,
pubmed-meshheading:9496390-Pain Measurement,
pubmed-meshheading:9496390-Quality of Life,
pubmed-meshheading:9496390-Treatment Outcome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease.
|
|
pubmed:affiliation |
YCRC Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
